Navigation Links
May/June 2012 Annals of Family Medicine tip sheet
Date:5/14/2012

ief of face pain and congestion. The effect was most marked when patients were given longer durations of treatment (21 days) and higher doses of medication. In their analysis, the researchers found that whereas 66 percent of patients would experience improvement or resolution of symptoms at 14 to 21 days using a placebo, an additional 7 percent of patients would achieve this outcome with corticosteroids, equating to a number needed to treat of 13. This clinical benefit, the authors note, must be set against the potential harms of medication and cost implications. They call for additional research comparing intranasal corticosteroids with placebo in the absence of antibiotics to clarify the time-course of clinical benefit and the impact on work and quality of life.

In an accompanying editorial, a family physician argues nasal steroids are not the answer for most patients. Most patients, he asserts, want to get better in a few days, not three weeks. Furthermore, he argues, the symptom relief offered by nasal steroids is minimal, and the cost is high relative to other over-the-counter drugs, like pseudoephedrine and ibuprofen, that offer similar relief at a fraction of the cost. He concludes instead of writing a prescription, treatment should focus on symptom relief.

Intranasal Corticosteroids in Management of Acute SinusitisA Systematic Review and Meta-Analysis

By Gail Hayward, MBBChir, DPhil, et al

Oxford University, England

Intranasal Steroids for Acute Sinusitis?

By John Hickner, MD, MSc

Case Western Reserve School of Medicine, Cleveland

Study: Electronic Health Record Use Does Not Lead to Better Diabetes Care

Even after the potentially disruptive phase of initial electronic health record implementation, quality improvements may remain elusive. Analyzing data over three years for 798 diabetic patients at 16 EHR-using and 26 non‒EHR-using practices, researchers found EHR use was not associated with better
'/>"/>

Contact: Angela Sharma
asharma@aafp.org
913-269-2269
American Academy of Family Physicians
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. News tips from the May/June issue of Physiological and Biochemical Zoology
2. The Hastings Center Report table of contents for May/June 2010
3. Annals of Internal Medicine tip sheet for May 8, 2012, online issue
4. January/February 2012 Annals of Family Medicine
5. November/December 2011 Annals of Family Medicine Tip Sheet
6. September/October 2011 Annals of Family Medicine Tip Sheet
7. Embargoed news from Annals of Internal Medicine
8. Embargoed news from Annals of Internal Medicine
9. Annals and ACP announce recipients of Junior Investigator Recognition Award
10. Prix Galien winners published in Annals of the New York Academy of Sciences
11. March/April 2011 Annals of Family Medicine tip sheet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... new pain relief targets that could be used ... at King,s College London made the discovery when ... periphery of the body. , Dr Marzia Malcangio ... underlying pain generation and our findings could help ... , One potential side effect of some chemotherapy ...
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
(Date:4/17/2014)... 17, 2014) Doctors who treat patients with ... (LAM) can face an agonizing treatment decision. , ... disease and help relieve shortness of breath. But ... sirolimus can cause potentially fatal complications following transplantation. ... Daniel Dilling, medical director of Loyola University Medical ...
(Date:4/17/2014)... from Boston University School of Medicine (BUSM) have ... consumption in an experimental model. The findings, reported ... Alcohol Abuse , may lead to more effective ... is one of the leading causes of illness ... negative economic impact by limiting the productivity of ...
(Date:4/17/2014)... 2014) Population Council scientists and their partners have found ... can prevent the transmission of multiple sexually transmitted infections ... HIV, herpes simplex virus 2 (HSV-2), and human papillomavirus ... that the gel is effective against multiple strains of ... vagina against all three viruses of at least eight ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2
... are inadequate in countries with high rates of multi-drug ... MDR-TB, patients are nearly twice as likely to fail ... rates, according to a new analysis of World Health ... TB treatment regimens need to updated and revised to ...
... completion of health risk assessment resulted in a 65% employee completion rate; ... ... 1, 2008 -- Employers are increasingly using incentives as the carrot to ... brief from HealthFitness (OTC BB: HFIT) zeros in on the use of ...
... Nearly six million people in the UK have had self-inflicted DIY disasters. ... home insurance as a result. , ... Cardiff, UK (PRWEB) August 1, ... disasters, according to Confused.com - the UK,s leading insurance price comparison site., ...
... in the document scanning industry, announced that its ... http://www.imagedocusa.com . The site introduces a ... businesses to "Go Paperless!" ImageDoc USA, headquartered ... and has created a reputation as a niche ...
... World Vision calls for action to protect, care for children impacted by ... HIV and AIDS, ... ... Aug. 1 A leading humanitarian agency has,today warned that the world,s biggest conference on ...
... shows that cannabinoid cell surface receptor CB1 plays a ... the Aug. 1 edition of the journal Cancer ... and nausea, elevating mood and stimulating appetite by serving ... signaling molecules. It now may serve as a new ...
Cached Medicine News:Health News:Strategies to control TB outdated, inadequate 2Health News:HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power's Employee Health and Wellness Initiative New Issue Brief Highlights AEP program, Outlines Elements for Success 2Health News:HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power's Employee Health and Wellness Initiative New Issue Brief Highlights AEP program, Outlines Elements for Success 3Health News:DIY Disasters Cost the Average Brit 669.58, Says Confused.com* 2Health News:DIY Disasters Cost the Average Brit 669.58, Says Confused.com* 3Health News:ImageDoc USA, Inc. Launches "Go Paperless!" Website 2Health News:International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children 2Health News:International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children 3Health News:Turned-off cannabinoid receptor turns on colorectal tumor growth 2Health News:Turned-off cannabinoid receptor turns on colorectal tumor growth 3
(Date:1/15/2014)... Quebec , Jan. 15, 2014  Valeant Pharmaceuticals International, ... announced that the applicable waiting period under the Hart-Scott-Rodino ... the previously announced tender offer by its indirect wholly-owned ... outstanding shares of common stock of Solta Medical, Inc. ...
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that it expects revenues for the fourth quarter ... full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... -- Acumed,s new SLIC Screw System - a jointed ... place and insert the screw accurately - offers surgeons ... repair or reconstruction as it holds the bones reduced ... http://photos.prnewswire.com/prnh/20140114/MN45636 ) The SLIC Screw is ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... REMICADE Therapy is More Likely to Induce Steroid-Free Remission ... ... Data presented for the first time,from the Phase 3b Study ... may provide new insights into,the approach to care of patients with ...
... More than 60 percent of moderate to severe ... achieved endoscopic remission at Week 10,in data from ... College,of Gastroenterology (ACG) Annual Scientific Meeting, ORLANDO, ... from a,large, prospective study investigating endoscopic improvement in ...
Cached Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7
... three preferred cardiac markers are ... immunoassay system. Cardiac Troponin I ... very high sensitivity and specificity ... appears very soon following AMI. ...
IRMA kit for detection of the cardiac marker Myoglobin...
... For the quantitative determination of myoglobin ... Myoglobin ELISA test is based on the ... assay. The assay system utilizes a unique ... determinant on the myoglobin molecule. Mouse monoclonal ...
... Prolactin ELISA kit is used for the ... or plasma. Human prolactin (lactogenic hormone) is ... molecular weight of approximately 23,000 daltons. The ... phase direct sandwich ELISA method. The samples ...
Medicine Products: